| Financial Year |
March 31 2023 |
| Monetary Funds |
241,974,327.46 |
| Held-for-trading Financial Assets |
25,000,000.00 |
| Notes Receivable |
81,985,186.98 |
| Accounts Receivable |
513,408,412.48 |
| Advances to Suppliers |
18,865,516.77 |
| Other Receivables |
5,761,454.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
212,823,601.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,703,959.57 |
| Total Current Assets |
1,145,636,153.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,706,623.12 |
| Investment Properties |
-- |
| Fixed Assetes |
587,268,346.89 |
| Under-construction Projects |
88,942,074.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,124,526.12 |
| R&D expenses |
-- |
| Goodwill |
34,424,104.95 |
| Long-Term Deferred and Prepaid Expenses |
10,914,943.99 |
| Deferred Income Tax Assets |
16,947,670.53 |
| Other Non-Current Assets |
4,789,248.11 |
| Sub-Total of Non-Current Assets |
911,600,581.17 |
| Total Assets |
2,057,236,734.52 |
| Short-Term Loans |
126,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,147,451.64 |
| Accounts Payable |
225,211,384.50 |
| Accounts Received In Advance |
160,111.06 |
| Employee Compensation Payable |
20,408,202.86 |
| Taxes Payable |
8,652,457.64 |
| Interest Payable |
818,704.23 |
| Dividend Payable |
-- |
| Other payables |
39,299,202.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
350,522,231.73 |
| Other Current Liabilities |
86,555.35 |
| Sub-Total of Current Liabilities |
807,641,078.94 |
| Long-term Loans |
227,980,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
15,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,536,520.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
283,399,484.69 |
| Total Liabilities |
1,091,040,563.63 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
308,745,364.20 |
| Surplus Reserve |
25,065,097.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
302,863,151.32 |
| Minority Stockholder's Interest |
191,649,442.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
774,546,728.26 |
| Owner's Equity（Stockholder's Equity） |
966,196,170.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,057,236,734.52 |
